Commentary: Tolvaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD) - an update
Commentary: Tolvaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD) - an update is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Commentary: Tolvaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD) - an update have?
Commentary: Tolvaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD) - an update has 11 citations in the OpenAlex counts ScholarIQ stores.
When was Commentary: Tolvaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD) - an update published?
Commentary: Tolvaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD) - an update has 2025 year in the ScholarIQ index.
What is the open-access status of Commentary: Tolvaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD) - an update?
Commentary: Tolvaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD) - an update has gold oa status in the ScholarIQ index.
What is the DOI of Commentary: Tolvaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD) - an update?
The DOI for Commentary: Tolvaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD) - an update is on the source record.
What is the PMID of Commentary: Tolvaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD) - an update?
The PMID for Commentary: Tolvaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD) - an update is on the source record.
What is the OpenAlex record for Commentary: Tolvaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD) - an update?
The OpenAlex for Commentary: Tolvaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD) - an update is on the source record.